Does the patient have a mitochondrial encephalomyopathy?

Journal of Child Neurology

Volumn 14, Issue SUPPL. 1, 1999, Pages

  DiMauro, Salvatore ^a   Bonilla, Eduardo ^a   De Vivo, Darryl C ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TRANSFER RNA;

ARTICLE; CLINICAL FEATURE; ELECTRON MICROSCOPY; ENCEPHALOMYOPATHY; EXERCISE TEST; FAMILY HISTORY; GENETIC COUNSELING; HUMAN; IMMUNOHISTOCHEMISTRY; INHERITANCE; MOLECULAR GENETICS; MUSCLE; MUSCLE BIOPSY; NEURORADIOLOGY; OXIDATIVE PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RESPIRATORY CHAIN;

EID: 0032753146     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073899014001051     Document Type: Article

References (55)

1. DiMauro S, Bonilla E: Mitochondrial encephalomyopathies, in Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds): The Molecular and Genetic Basis of Neurological Disease, 2nd ed. Boston, Butterworth-Heinemann, 1997, pp 201-235.
2. DiDonato S: Diseases associated with defects of beta-oxidation, in Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds): The Molecular and Genetic Basis of Neurological Disease, 2nd ed. Boston, Butterworth-Heinemann, 1997, pp 939-956.
3. De Vivo DC, Hirano M, DiMauro S: Mitochondrial disorders, in Vinken PJ, Bruyn GW (eds): Neurodystrophies and Neurolipidoses. Amsterdam, Elsevier, 1996, pp 389-446.
4. Schon EA: The mitochondrial genome, in Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds): The Molecular and Genetic Basis of Neurological Disease. Boston, Butterworth-Heinemann, 1997, pp 189-200.
5. DiMauro S, Schon EA: Mitochondrial DNA and diseases of the nervous system: The spectrum. Neuroscientist 1998;4:53-63.
6. DiMauro S, Hirano M, Bonilla E, De Vivo DC: The mitochondrial disorders, in Berg BO (ed): Principles of Child Neurology. New York, McGraw-Hill, 1996, pp 1201-1232.
7. Moraes CT, Zeviani M, Schon EA, et al: Mitochondrial DNA deletion in a girl with features of Kearns Sayre and Lowe syndromes: An example of phenotypic mimicry? Am J Med Genet 1991;41: 301-305.
8. Uziel G, Moroni I, Lamantea E, et al: The mitochondrial disease associated with the T8993G mutation of mitochondrial ATPase 6 gene: A clinical, biochemical, and molecular study in six families. J Neurol Neurosurg Psychiatry 1997;63:16-22.
9. Pons R, Andreetta F, Wang CH, et al: Mitochondrial myopathy simulating spinal muscular atrophy. Pediatr Neurol 1996;15:153-158.
10. Loeffen J, Smeitink J, Triepels R, et al: The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 1998;63:1598-1608.
11. van den Heuvel L, Ruitenbeek W, Smeets R, et al: Demonstration of a new pathogenic mutation in human complex I deficiency: A 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am J Hum Genet 1998;62:262-268.
12. Triepels RH, van den Heuvel LP, Loeffen JLCM, et al: Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann Neurol 1999;45:787-790.
13. Bourgeron T, Rustin P, Chretien D, et al: Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995;11:144-149.
14. DiMauro S, Hirano M: Mitochondria and heart disease. Curr Opin Cardiol 1998;13:190-197.
15. Silvestri G, Bertini E, Servidei S, et al: Maternally inherited cardiomyopathy: A new phenotype associated with the A to G at nt. 3243 of mitochondrial DNA (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes mutation). Muscle Nerve 1997;20:221-225.
16. Vilarinho L, Santorelli FM, Rosas MJ, et al: The mitochondrial A3243G mutation presenting as severe cardiomyopathy. J Med Genet 1997;34:607-609.
17. Goto Y, Tojo M, Tohyama J, et al: A novel point mutation in the mitochondrial tRNALeu(UUR) gene in a family with mitochondrial myopathy. Ann Neurol 1992;31:672-675.
18. Ogle RF, Christodoulou J, Fagan E, et al: Mitochondrial myopathy with tRNALeu(UUR) mutation and complex I deficiency responsive to riboflavin. J Pediatr 1997;130:138-145.
19. Leu(UUR) gene associated with familial myopathy. J Neurol Sci 1999;164:153-157.
20. Silvestri G, Santorelli FM, Shanske S, et al: A new mtDNA mutation in the tRNA(LeuUUR) gene associated with maternally inherited cardiomyopathy. Hum Mutat 1994;3:37-43.
21. Schon EA, Bonilla E, DiMauro S: Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 1997;29:131-149.
22. Moraes CT, Ciacci F, Bonilla E, et al: Two novel pathogenic mtDNA mutations affecting organelle number and protein synthesis: Is the tRNA-Leu(UUR) gene an etiologic hot spot? J Clin Invest 1993;92: 2906-2915.
23. Andreu AL, Tanji K, Bruno C, et al: Exercise intolerance due to a nonsense mutation in the mtDNA ND4 gene. Ann Neurol 1999; 45:820-823.
24. Dumoulin R, Sagnol I, Ferlin T, et al: A novel gly290asp mitochondrial cytochrome b mutation linked to a complex III deficiency in progressive exercise intolerance. Mol Cell Probes 1996;10: 389-391.
25. Andreu AL, Bruno C, Shanske S, et al: Missense mutation in the mtDNA cytochrome b gene in a patient with myopathy. Neurology 1998;51:1444-1447.
26. Andreu AL, Bruno C, Dunne TC, et al: A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria. Ann Neurol 1999;45:127-130.
27. Keightley JA, Hoffbuhr KC, Burton MD, et al: A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria. Nat Genet 1996;12:410-415.
28. Gattermann N, Retzlaff S, Wang YL, et al: Heteroplasmic point mutations of mitochondrial DNA subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia. Blood 1997;90:4961-4972.
29. Moraes CT, Ciacci F, Silvestri G, et al: Atypical clinical presentations associated with the mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes mutation at position 2343 of human mitochondrial DNA. Neuromuscul Disord 1993;3:43-50.
30. Zeviani M, Servidei S, Gellera C, et al: An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989;339:309-311.
31. Carrozzo R, Hirano M, Fromenty B, et al: Multiple mitochondrial DNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses. Neurology 1998;50:99-106.
32. Suomalainen A, Kaukonen J, Amati P, et al: An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet 1995;9:146-151.
33. Kaukonen JA, Amati P, Suomalainen A, et al: An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p. Am J Hum Genet 1996;58:763-769.
34. Bohlega S, Tanji K, Santorelli FM, et al: Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1996;46:1329-1334.
35. Bardosi A, Creutzfeldt W, DiMauro S, et al: Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol (Berl) 1987;74:248-258.
36. Hirano M, Silvestri G, Blake D, et al: Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994;44:721-727.
37. Hirano M, Garcia-de-Yebenes J, Jones AC, et al: Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome maps to chromosome 22q13.32-qter. Am J Hum Genet 1998;63:526-533.
38. Nishino I, Spinazzola A, Hirano M: Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689-692.
39. Robinson BH: Lactic acidemia (disorders of pyruvate carboxylase, pyruvate dehydrogenase), in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease, vol 2, 7th ed. New York, McGraw Hill, 1995, pp 1479-1499.
40. De Vivo DC, DiMauro S: Mitochondrial disease, in Swaiman KF (ed): Pediatric Neurology: Principles and Practice. St Louis, Mosby, 1994, pp 1335-1356.
41. 1H MRSI, MRSI and neuropsychological testing. Abstract presented at the 7th Scientific Meeting of the International Society for Magnetic Resonance in Medicine, Philadelphia, PA, April 1999.
42. Bank W, Park J, Lech G, Chance B: Near-infrared spectroscopy in the diagnosis of mitochondrial disorders. Biofactors 1998;7: 243-245.
43. Argov Z, Bank WJ: Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders. Ann Neurol 1991;30:90-97.
44. Engel WK, Cunningham CG: Rapid examination of muscle tissue: An improved trichrome stain method for fresh-frozen biopsy sections. Neurology 1963;13:919-923.
45. DiMauro S, Schon EA: Nuclear power and mitochondrial disease. Nat Genet 1998;19:214-215.
46. Dahl H-HM: Getting to the nucleus of mitochondrial disorders: Identification of respiratory chain-enzyme genes causing Leigh syndrome. Am J Hum Genet 1998;63:1594-1597.
47. DiMauro S: Mitochondrial encephalomyopathies: Back to mendelian genetics. Ann Neurol 1999;45:693-694.
48. Adams PL, Lightowlers RN, Turnbull DN: Molecular analysis of cytochrome c oxidase deficiency in Leigh's syndrome. Ann Neurol 1997;41:268-270.
49. DiMauro S, Hirano M, Bonilla E, et al: Cytochrome oxidase deficiency: Progress and problems, in Schapira AHV, DiMauro S (eds): Mitochondrial Disorders in Neurology. Oxford, Butterworth-Heinemann, 1994, pp 91-115.
50. Tzagoloff A, Dieckmann CL: PET genes of Saccharomyces cerevisiae. Microbiol Rev 1990;54:211-225.
51. Zhu Z, Yao J, Johns T, et al: SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 1998;20:337-343.
52. Tiranti V, Hoertnagel K, Carrozzo R, et al: Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 1998;63:1609-1621.
53. Pandolfo M: Molecular genetics and pathogenesis of Friedreich ataxia. Neuromuscul Disord 1998;8:409-415.
54. Lutsenko S, Cooper MJ: Localization of the Wilson's disease protein product to mitochondria. Proc Natl Acad Sci U S A 1998;95:6004-6009.
55. Casari G, De Fusco M, Ciarmatori S, et al: Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998;93:973-983.